Ayalew Tefferi. Show Affiliations »
Abstract
Mesh: See more » Antimetabolites/therapeutic useBenzamidesCladribine/therapeutic useDrug EvaluationHumansImatinib MesylateInterferon-alpha/therapeutic useMastocytosis, Systemic/drug therapyMastocytosis, Systemic/geneticsOncogene Proteins, FusionPilot ProjectsPiperazines/therapeutic usePyrimidines/therapeutic useReceptor, Platelet-Derived Growth Factor alpha/geneticsmRNA Cleavage and Polyadenylation Factors/genetics
Substances: See more » AntimetabolitesBenzamidesInterferon-alphaOncogene Proteins, FusionPiperazinesPyrimidinesmRNA Cleavage and Polyadenylation FactorsCladribineImatinib MesylateFIP1L1-PDGFRA fusion protein, humanReceptor, Platelet-Derived Growth Factor alpha
Year: 2004 PMID: 14687615 DOI: 10.1016/j.leukres.2003.09.004
Source DB: PubMed Journal: Leuk Res ISSN: 0145-2126 Impact factor: 3.156